Related references
Note: Only part of the references are listed.The potential of fecal microbiota transplantation in systemic sclerosis
Anna-Maria Hoffmann-Vold et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
Havard Fretheim et al.
RHEUMATOLOGY (2020)
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
Havard Fretheim et al.
PLOS ONE (2020)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality
Nicolas Richard et al.
RHEUMATOLOGY (2019)
The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives
Federica Furini et al.
FRONTIERS IN MEDICINE (2019)
Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features
Anna-Maria Hoffmann-Vold et al.
RMD OPEN (2019)
Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients
E. K. Stern et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group
Sabine Adler et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Increased Incidence of Gastrointestinal Side Effects in Patients Taking Hydroxychloroquine: A Brand-related Issue?
AMAR SRINIVASA et al.
JOURNAL OF RHEUMATOLOGY (2017)
The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review
Y. Mostmans et al.
AUTOIMMUNITY REVIEWS (2017)
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
Dinesh Khanna et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
Ariane L. Herrick et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis
Jasmin Raja et al.
RHEUMATOLOGY (2016)
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey
Camelia Frantz et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis
Jessica Meijs et al.
RMD OPEN (2016)
The multidisciplinary health care team in the management of stenosis in Crohn's disease
Marco Gasparetto et al.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2015)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Measuring response in the gastrointestinal tract in systemic sclerosis
Dinesh Khanna et al.
CURRENT OPINION IN RHEUMATOLOGY (2013)
Systemic sclerosis and the gut
Shamaila Butt et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Prevalence of systemic sclerosis in south-east Norway
Anna-Maria Hoffmann-Vold et al.
RHEUMATOLOGY (2012)
Gastrointestinal Manifestations of Scleroderma: Recent Progress in Evaluation, Pathogenesis, and Management
Genevieve Gyger et al.
CURRENT RHEUMATOLOGY REPORTS (2012)
Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2011)
Toxicity and Monitoring of Immunosuppressive Therapy Used in Systemic Autoimmune Diseases
Keith C. Meyer et al.
CLINICS IN CHEST MEDICINE (2010)
Reliability and Validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
Dinesh Khanna et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Improvement of Severe Systemic Sclerosis-associated Gastric Antral Vascular Ectasia Following Immunosuppressive Treatment with Intravenous Cyclophosphamide
Steffan W. Schulz et al.
JOURNAL OF RHEUMATOLOGY (2009)
The epidemiology of glucocorticoid-associated adverse events
Allyson K. McDonough et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument
Dinesh Khanna et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Mycophenolate mofetil is safe, well tolerated, and preserves lung function, in patients with connective tissue disease-related interstitial lung disease
Jeffrey J. Swigris et al.
CHEST (2006)
Share Paper
